MITRA — Mithra Pharmaceuticals SA Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Mithra Pharmaceuticals Obtains Equity Funding For Up To EUR 100 Million
Mithra jumps on positive results from Donesta late-stage trial
Brief: Mithra: Positive Top-Line Results From Donesta Phase 3 Studies In Menopausal Women
Citi says Mayne Pharma's Nextstellis launch taking longer than expected, cuts PT
Brief: Mithra Pharmaceuticals Issues Put Option Notice Under Agreement With LDA Capital
Mithra Pharmaceuticals jumps on new pipeline updates
Brief: Mithra Pharmaceuticals And Mayne Pharma Announce TGA Approval Of Nextstellis
Brief: Mithra Pharmaceuticals Extends Studies Of Donesta Clinical Program
Brief: Mithra Pharmaceuticals Confirms Appointment Of Leon Van Rompay As CEO
Brief: Mithra Pharmaceuticals: Mayne Pharma Received A CRL From The FDA Regarding Myring
Brief: Mithra Pharmaceuticals Announces Topline Results For COVID-19 Phase II Study
Brief: Mithra Pharmaceuticals H1 Net Loss Widens To 54.9 Million Euros
Brief: Mithra Pharmaceuticals Says PeriNesta Project Is No Longer Its Priority
Brief: Mithra Pharmaceuticals Announces Approval Of Oral Contraceptive Estelle In Russia
Brief: ExeVir, Mithra Announce Manufacturing Collaboration For Innovative COVID-19 Treatments
Brief: Mithra Issues Put Option Notice Under Capital Agreement With LDA Capital
Brief: Mithra Successfully Renegotiates Earnouts Relating To Its Complex Therapeutics
Brief: Mithra Completes Recruitment Of COVID-19 Phase II Study
hold-BUZZ-Mithra: Rises as drug Estelle wins FDA marketing exclusivity